paclitaxel has been researched along with Bornholm Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamura, T; Kawagoe, H; Kumagai, S; Matsuo, G; Nishida, T; Nishio, S; Ota, S; Sugiyama, T; Ushijima, K | 1 |
| Ellis, GK; Garrison, JA; Gralow, JR; Linden, HM; Livingston, RB; McCune, JS; West, HL | 1 |
1 review(s) available for paclitaxel and Bornholm Disease
| Article | Year |
|---|---|
Myalgias and arthralgias associated with paclitaxel.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Arthralgia; Dose-Response Relationship, Drug; Drug Hypersensitivity; Humans; Incidence; Paclitaxel; Pleurodynia, Epidemic; Severity of Illness Index | 2003 |
1 other study(ies) available for paclitaxel and Bornholm Disease
| Article | Year |
|---|---|
Weekly 1-h paclitaxel infusion in patients with recurrent endometrial cancer: a preliminary study.
Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Agents, Phytogenic; Disease Progression; Drug Evaluation; Endometrial Neoplasms; Female; Humans; Infusions, Intravenous; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Neurotoxicity Syndromes; Paclitaxel; Peripheral Nervous System Diseases; Pleurodynia, Epidemic; Severity of Illness Index; Survival Analysis; Time Factors; Treatment Outcome; Women's Health | 2003 |